Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Clinical issues in the management of patients with myelodysplasia.

Schiffer CA.

Hematology Am Soc Hematol Educ Program. 2006:205-10. Review.

PMID:
17124062
2.

[Myelodysplastic syndromes. Diagnosis and therapeutic strategies].

Aul C, Giagounidis A, Germing U, Ganser A.

Med Klin (Munich). 2002 Nov 15;97(11):666-76. Review. German.

PMID:
12434275
3.

Myelodysplastic Syndromes: Diagnosis and Treatment.

Steensma DP.

Mayo Clin Proc. 2015 Jul;90(7):969-83. doi: 10.1016/j.mayocp.2015.04.001. Review.

PMID:
26141335
4.

Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.

Garcia-Manero G.

Am J Hematol. 2011 Jun;86(6):490-8. doi: 10.1002/ajh.22047. Review.

5.

Optimal sequencing of treatments for patients with myelodysplastic syndromes.

Itzykson R, Fenaux P.

Curr Opin Hematol. 2009 Mar;16(2):77-83. doi: 10.1097/MOH.0b013e3283257a74. Review.

PMID:
19468268
6.

Myelodysplastic syndromes.

Scott BL, Deeg HJ.

Annu Rev Med. 2010;61:345-58. doi: 10.1146/annurev.med.051308.132852. Review.

PMID:
20059342
7.

How to treat MDS without stem cell transplantation.

Gattermann N.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S30-6. doi: 10.1016/j.bbmt.2009.10.017. Review.

8.

Hematopoietic stem cell transplantation for myelodysplastic syndrome.

Parmar S, de Lima M.

Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S37-44. doi: 10.1016/j.bbmt.2009.10.018. Review.

9.

Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes.

Abel GA, Koreth J.

Curr Opin Hematol. 2013 Mar;20(2):150-6. doi: 10.1097/MOH.0b013e32835d8e8e. Review.

PMID:
23298879
10.

High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond.

Gergis U, Wissa U.

Curr Hematol Malig Rep. 2010 Jan;5(1):1-8. doi: 10.1007/s11899-009-0035-0. Review.

PMID:
20425390
11.

Stem cell transplantation and intensified cytotoxic treatment for myelodysplasia.

Boogaerts MA.

Curr Opin Hematol. 1998 Nov;5(6):465-71. Review.

PMID:
9814657
12.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T.

Biol Blood Marrow Transplant. 2009 Feb;15(2):137-72. doi: 10.1016/j.bbmt.2008.12.003. Review. Erratum in: Biol Blood Marrow Transplant. 2009 May;15(5):650.

13.

Current therapy of myelodysplastic syndromes.

Zeidan AM, Linhares Y, Gore SD.

Blood Rev. 2013 Sep;27(5):243-59. doi: 10.1016/j.blre.2013.07.003. Review.

14.

Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.

Beran M.

Int J Hematol. 2000 Aug;72(2):139-50. Review.

PMID:
11039661
15.

Transplant for MDS: challenges and emerging strategies.

Tamari R, Castro-Malaspina H.

Best Pract Res Clin Haematol. 2015 Mar;28(1):43-54. doi: 10.1016/j.beha.2014.11.006. Review.

PMID:
25659729
16.

Update on the pharmacotherapy for myelodysplastic syndromes.

Duong VH, Komrokji RS, List AF.

Expert Opin Pharmacother. 2014 Sep;15(13):1811-25. doi: 10.1517/14656566.2014.937705. Review.

PMID:
25080144
17.

The role of hematopoietic cell transplantation as therapy for myelodysplasia.

Appelbaum FR.

Best Pract Res Clin Haematol. 2011 Dec;24(4):541-7. doi: 10.1016/j.beha.2011.09.010. Review.

PMID:
22127318
18.

Emerging therapeutic strategies for myelodysplastic syndrome.

Barrett J, Battiwalla M.

Curr Hematol Rep. 2003 May;2(3):193-201. Review.

PMID:
12901340
19.

Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes.

Gore SD, Hermes-DeSantis ER.

Cancer Control. 2009 Oct;16 Suppl:2-10. Review.

20.

Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome.

Cutler C.

Hematology Am Soc Hematol Educ Program. 2010;2010:325-9. doi: 10.1182/asheducation-2010.1.325. Review.

PMID:
21239814

Supplemental Content

Support Center